12-45302037-A-T
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_001025356.3(ANO6):c.94A>T(p.Ile32Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000489 in 1,613,926 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001025356.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANO6 | NM_001025356.3 | c.94A>T | p.Ile32Phe | missense_variant | 2/20 | ENST00000320560.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANO6 | ENST00000320560.13 | c.94A>T | p.Ile32Phe | missense_variant | 2/20 | 1 | NM_001025356.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00283 AC: 430AN: 152136Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000688 AC: 173AN: 251304Hom.: 0 AF XY: 0.000427 AC XY: 58AN XY: 135806
GnomAD4 exome AF: 0.000246 AC: 360AN: 1461672Hom.: 0 Cov.: 32 AF XY: 0.000221 AC XY: 161AN XY: 727140
GnomAD4 genome AF: 0.00282 AC: 430AN: 152254Hom.: 1 Cov.: 33 AF XY: 0.00289 AC XY: 215AN XY: 74460
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 12, 2024 | Variant summary: ANO6 c.94A>T (p.Ile32Phe) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00049 in 1606956 control chromosomes, predominantly at a frequency of 0.0092 within the African or African-American subpopulation in the gnomAD database, including 1 homozygote. To our knowledge, no occurrence of c.94A>T in individuals affected with Scott Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 2051043). Based on the evidence outlined above, the variant was classified as benign. - |
ANO6-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 25, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at